Post #LVAD late #RHF causes ⬆️ mortality/morbidity 🔥no standardized definition 🔥> 90 days post implant 🔥⬆️ Cr/LFTs; ⬆️ diuretic dose Phenomenal 🔥🔥review JACC Journals #JACCHF by @IRajapreyar Ryan J Tedford MD Yevgeniy Brailovsky DO MSc FACC Alexander Hajduczok, MD 🇺🇦🙏 & team 🙌 #ACCEarlyCareer #ACCFIT

📣1 week for 2023 #CSWG Global Summit Learn all things #Shock Didactics, discussions & debates by experts. All #FME 📆 June 21, 2023 🕰️3-7.30 PM EST Register 👉cardiogenicshocksummit.org Navin Kapur @manreetkanwar Dr. Claudius Mahr, FACC, FESC, FRSM Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Jaime Hernandez-Montfort Jacob Abraham, MD

There is still time to register and attend our @NYPCUCVI Heart Transplant Summit this Friday 6/23 The latest updates in Heart Transplantation. Don’t miss it! Link to register: eventleaf.com/Attendee/Atten…

We got the sneak peak 2 weeks ago! 👏🏻👏🏻 congratulations Jon Grinstein MD

Saving Two Babies’ Lives With One Pioneering Approach to Heart Valve Transplantation healthmatters.nyp.org/saving-two-bab…

Lessons Learned from World’s First Successful Transplant of Genetically-Modified Pig Heart into Human Patient: UM School of Medicine Researchers Detail Inflammatory Process & Heart Damage in Lancet Study in Preparation for Future Transplants bit.ly/44ezBDD

Big news indeed! “The outstanding results of the ATTRibute-CM study provide new hope to patients living with transthyretin amyloid cardiomyopathy, or ATTR-CM”, said Dr. Daniel Judge, Professor of Medicine/Cardiology MUSC Health & Co-Chair of the ATTRibute-CM Steering Committee"

Proud to present results of the Donor Heart Study! Of 4,333 brain dead donors, 13% had LV dysfunction. This was usually reversible and had no impact on heart tx recipient survival. Another reason to #StartWithYes ahajournals.org/doi/10.1161/CI… Stanford Heart Failure, Cardiac Transplant and MCS Jeff Teuteberg Eldrin Lewis

🚨 First (of many!) publication from Kiran Khush's Donor Heart Study: 1⃣~ 60% of donor 🫀 with ⬇️EF were reversible within a day‼️ 2⃣Donor 🫀 ⬇️ EF was not assoc with 1 yr survival‼️ Huge implications for the field‼️ Circulation The ISHLT TCC Community of Practice (TCC COP) - AST @StanfordCTSurg HFSA Yas Moayedi

With the goal of mitigating late hemodynamic related events (HDRE), I am excited to share our new classification system which quantifies the net hemodynamic burden of long term VAD support. ahajournals.org/doi/abs/10.116… Jennifer Cowger Ryan J Tedford MD @Brian_Houston12 Mark Belkin

This review does not disappoint. All AHFTX fellows out there, this is required reading! UT Southwestern Internal Medicine UTSW Heart Columbia Medicine Vanessa Blumer, MD, FACC, FHFSA Robert Mentz, MD Jeff Teuteberg Khue Ton Josef Stehlik Stavros George Drakos Jennifer Haythe MD

🫀A New Era in Heart Transplantation Manish Patel, MD & Ismael Salas MD FACS utilized the only FDA-approved technology for #organtransplants revolutionizing donor #heart preservation. This device mimics a living heart's state & expands our donor pool. UTHealth Houston Memorial Hermann

UMD ❤️ Fellows and Faculty at IXA (International Xenotransplantation Association) Conference in ☀️San Diego this weekend. Congrats to Cullen Soares (3rd Yr), Oneib Khan (2nd Yr) and Drs. Hong-Zohlman, Dickfeld, and Ananthram on their important work!

PET guided interventions significantly improves survival probability for well-defined severity of coronary flow capacity - academic.oup.com/eurheartj/arti… @MDSachinKumar Abhijeet Dhoble

#CSWG data from Jaime Hernandez-Montfort @manreetkanwar Saraschandra Vallabhajosyula, MD MSc MOHIT PAHUJA Elric Zweck Maryjane Farr MD MSc, FACC FAST FHFSA FAHA Navin Kapur: women had worse outcomes, ⬆️complications & were less likely to receive OHT or LVAD JACC Journals #JACCHF jacc.org/doi/full/10.10… Editorial jacc.org/doi/10.1016/j.…

#CardioTwitter #AHA UTHealth Houston Memorial Hermann Join us this coming March 2024 in hearing Mariell Jessup Keynote Address Houston Shock Symposium! HoustonShock.org

Exciting times in heart transplantation! Great editorial and excellent collection of articles reviewing ex-situ machine perfusion and its applications in heart transplantation including ex-situ biological modification followed by allo- or auto-transplant! frontiersin.org/journals/cardi…

🔥🔥 Read all about Donor Selection for Heart Transplantation in 2025 🫀🫀 JACC Journals #JACCHF by #RashmiJain #EvanKransdorf Jennifer Cowger Valluvan Jeevanandam, MD #JonKobashigawa 👉 jacc.org/doi/full/10.10…